Results 251 to 260 of about 3,211,899 (373)

Context-dependent roles of complement in cancer

Nature Reviews. Cancer, 2019
L. Roumenina, Marie V. Daugan, F. Petitprez, C. Sautès-Fridman, W. Fridman   +4 more
semanticscholar   +1 more source

Longitudinal Study of Salivary Biomarkers in the Definition of Clinico‐Molecular Progression of Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
Longitudinal changes in salivary biomarkers in Parkinson’s disease (PD) from early (T0) to 4‐year follow‐up (T1), quantified by ELISA: oligomeric and total α‐synuclein, total and phosphorylated tau, MAP1LC3B (autophagy), and TNFa (inflammation). Blue arrows indicate direction of change at T1 vs T0 (up = increase; down = decrease).
Maria Ilenia De Bartolo, Daniele Belvisi, Matteo Costanzo, Claudia Caturano, Francesco Emanuele Bellomi, Carolina Cutrona, Flavia Aiello, Giorgio Leodori, Massimo Marano, Romina Mancinelli, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Giorgio Vivacqua   +13 more
wiley   +1 more source

Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network. [PDF]

Front Immunol
Wang L, Chen J, Li H, Wang L, Liu F, Jiang X.   +5 more
europepmc   +1 more source

Relationships Among Complement-Fixing Values, Infectious Endpoints, and Death Curves in Experimental Coxiella Burnetii Infection [PDF]

, 1951
Richard A. Ormsbee, David B. Lackman, Edgar G. Pickens   +2 more
openalex   +1 more source

C3 glomerulopathy — understanding a rare complement-driven renal disease

Nature Reviews Nephrology, 2019
Richard J. H. Smith, G. Appel, A. Blom, H. Cook, V. D’Agati, F. Fakhouri, V. Frémeaux-Bacchi, M. Józsi, D. Kavanagh, John D Lambris, M. Noris, M. Pickering, G. Remuzzi, S. R. de Córdoba, S. Sethi, J. van der Vlag, P. Zipfel, C. Nester   +17 more
semanticscholar   +1 more source

Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross‐Sectional Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Managing long COVID in people with multiple sclerosis and related disorders (pwMSRD) is complex due to overlapping symptoms. To address evidence gaps, we evaluated long COVID susceptibility in pwMSRD versus controls and its associations with multi‐domain function and disability.
Chen Hu, Jiyeon Son, Lindsay McAlpine, Elizabeth L. S. Walker, Megan Dahl, Emily Song, Sugeidy Ferreira Brito, Katelyn Kavak, Kaho Onomichi, Amit Bar‐Or, Christopher Perrone, Claire S. Riley, Bianca Weinstock‐Guttman, Philip L. De Jager, Erin E. Longbrake, Zongqi Xia   +15 more
wiley   +1 more source

The life-and-death struggle between the complement system and pathogens: Mechanisms of elimination, evasion tactics, and translational potential. [PDF]

Virulence
Lian S, Liu J, Yang Y, Zhu G, Xia P.
europepmc   +1 more source

Hemolysis with Complement of Intact Azo-Erythrocytes Sensitized with Antisera Homologous to the Attached Azo-Grouping [PDF]

, 1952
Arthur M. Silverstein, Frank Maltaner
openalex   +1 more source

Analysis of Soluble Interleukin‐2 Receptor as a Prognostic Biomarker in NMOSD and MOGAD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Soluble interleukin‐2 receptor (sIL‐2R) is a biomarker for T cell activity. T cells are involved in neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) pathogenesis. However, sIL‐2R has so far not been evaluated in these conditions.
Philipp Klyscz, Carolin Otto, Klemens Ruprecht, Susanna Asseyer, Hannes Ole Tiedt, Christian Meisel, Judith Bellmann‐Strobl, Friedemann Paul, Patrick Schindler   +8 more
wiley   +1 more source

Correction: Probiotic preserving extract supplementation as a novel attitude in managing diabetes mellitus. [PDF]

BMC Complement Med Ther
Saadatzadeh A, Emamifar SMK, Mard SA, Ahangarpour A, Angali KA, Mehdialamdarlou S.   +5 more
europepmc   +1 more source